Feb 7th 2023 - Mar 21st 2023
Anavex's A2-73 Blarcamesine's trial result... See more
Complete Results!! !
The Motley Fool Stock Advisor has a track record that speaks for itself, with average recommendations that have returned over 542%*. Act now so you can start investing smarter, not harder.
*As of October 2023$79 is an introductory price for new members only. 60% discount based on the current list price of Stock Advisor of $199/year. Membership will renew annually at the then current list price.Feb 7th 2023 - Mar 21st 2023
$TGTX This gonna be amazing guys after they sell ... See more
Drug results are more effective and safer than ocr... See more
Anavex's A2-73 Blarcamesine's trial results on 2 previously completed adult phase-3 trials were highly successful.
Complete Results!! !
But the company actually has never seen before wonderful results.
If results hold up, the stock will achieve massive gains.
The results were excellent on the 2 completed adult trials, and because the 3rd trial is pediatric and early on the disease, they are expected to perform even better.
Alzheimer's is the most valuable and most difficult indication and most desired lately.. and only Anavex really has some great results with a great safety record. .
The sava results trounce you guys 🤦🏻♂️🤦🏻♂️🤦🏻♂️😂😂😂
Sava has potential and the phase 3 results will show the truth.
Sava has good results. .
But the company actually has never seen before wonderful results.
And, make no mistake, the result are impressive.
It is the best results that have been seen in AD.
Overall, results impressive.
This could be huge in eliminating artificial FUD against the top-line results.
$SAVA Market is moving higher as SAVA is expecting data results.
Anavex is late like the sun comes up and still produces great results.
MOST IMPORTANTLY, THE RESULTS MUST HAVE BEEN GOOD AND PROMISING at each snapshot that leads Remi to use the word "Thrilled" in Dec 6 PR.
$TGTX This gonna be amazing guys after they sell their product Lets say 50.000 usd for the dose and they sell 500 a month Make the math and tell me how revenue they will get every quarter
Drug results are more effective and safer than ocrevus + treatment is every 6 months vs every 6 weeks like the other drug.
$IMUX This week, $MDGL up 300% as a result of their NASH breakthrough.
